Work Here?
About Benchling
Industries
Enterprise Software
Biotechnology
Company Size
501-1,000
Company Stage
Series F
Total Funding
$400.7M
Headquarters
San Francisco, California
Founded
2012
Overview
Benchling provides a platform designed for life sciences research and development, primarily catering to biotech and pharmaceutical companies, academic institutions, and research organizations. Its cloud-based platform includes tools like an electronic lab notebook, molecular biology tools, and sample tracking systems, which help scientists manage experimental data, collaborate with colleagues, and streamline workflows. Users can design experiments, record results, and analyze data in an organized way. Benchling operates on a subscription-based model, offering different pricing tiers based on organizational size and feature needs, ensuring a steady revenue stream. The company differentiates itself by focusing on the specific needs of life sciences R&D, providing essential tools that enhance research efficiency and effectiveness. The goal of Benchling is to accelerate scientific research and facilitate the development of innovations in the life sciences sector.
Simplify's Take
What believers are saying
- Benchling's acquisition of PipeBio enhances AI-powered antibody discovery capabilities.
- Partnerships with companies like Sanofi accelerate digital transformation in pharmaceutical R&D.
- Growing demand for cloud-based solutions boosts Benchling's market potential.
What critics are saying
- Emerging biotech software platforms could erode Benchling's market share.
- Rapid AI advancements may require significant investment to maintain competitiveness.
- Data privacy concerns could undermine trust in Benchling's platform.
What makes Benchling unique
- Benchling offers a comprehensive cloud-based platform for life sciences R&D.
- The platform integrates AI and machine learning for advanced research capabilities.
- Benchling's tools facilitate collaboration and data sharing across global scientific teams.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$400.7M
Above
Industry Average
Funded Over
8 Rounds
Tiger Global
Benchmark
Y Combinator
Andreessen HorowitzBenefits
Four months of fully paid parental leave
401(k) plan
Remote working stipend
Yearly company-wide retreat
Monthly gym and wellness stipend
Commuter benefits
100% premiums covered for health, dental, and vision
Weekly company social events
Flexible PTO and company-wide winter holiday shutdown
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 1%2 year growth
↑ 1%We’re excited to announce Benchling’s acquisition of PipeBio, a leader in high-throughput bioinformatics analysis, to drive biologics discovery.
The collaboration is expected to improve the efficiency of the discovery process by combining PipeBio's advanced sequence analysis tools with Benchling's established software ecosystem.
In a significant move to streamline its R&D operations, Novonesis, a global leader in biosolutions, has selected Benchling as its digital platform to enhance the discovery, development, and testing processes across its scientific teams.
Under his leadership, Benchling expanded its customer base to over 1,000 companies, including more than 20 of the top 50 global biopharma companies and hundreds of emerging, growth, and enterprise biotechnology firms.
With heaps of creativity and now a new collaboration with H. Moser & Cie., Benc is starting to leave his "underdog" status behind.
Benchling is Hiring for 0 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Benchling
Industries
Enterprise Software
Biotechnology
Company Size
501-1,000
Company Stage
Series F
Total Funding
$400.7M
Headquarters
San Francisco, California
Founded
2012
Benchling is Hiring for 0 Jobs on Simplify!
Find jobs on Simplify and start your career today